Report cover image

Therapeutic Proteins and Oral Vaccines Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 133 Pages
SKU # APRC20352401

Description

Summary

According to APO Research, The global Therapeutic Proteins and Oral Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Therapeutic Proteins and Oral Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Therapeutic Proteins and Oral Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Therapeutic Proteins and Oral Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Therapeutic Proteins and Oral Vaccines include Abbott, Sanofi, Merck, Roche, Pfizer, Amgen, TransAlgae, Serum Institute of India and Novo Nordisk, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Proteins and Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Proteins and Oral Vaccines.
The Therapeutic Proteins and Oral Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Proteins and Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Therapeutic Proteins and Oral Vaccines Segment by Company

Abbott
Sanofi
Merck
Roche
Pfizer
Amgen
TransAlgae
Serum Institute of India
Novo Nordisk
MigVax
Lumen Bioscience
Johnson and Johnson
Emergent Biosolutions
Eli Lilly and Company
Biogen
Therapeutic Proteins and Oral Vaccines Segment by Type

Therapeutic Proteins
Oral Vaccines
Therapeutic Proteins and Oral Vaccines Segment by Application

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Therapeutic Proteins and Oral Vaccines Segment by Application

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Therapeutic Proteins and Oral Vaccines Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Proteins and Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Proteins and Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Proteins and Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Therapeutic Proteins and Oral Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

133 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Therapeutic Proteins and Oral Vaccines by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Therapeutic Proteins
2.2.3 Oral Vaccines
2.3 Therapeutic Proteins and Oral Vaccines by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Retail Pharmacies
2.3.3 Online Pharmacies
2.3.4 Hospital Pharmacies
2.4 Assumptions and Limitations
3 Therapeutic Proteins and Oral Vaccines Breakdown Data by Type
3.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Type (2020-2025)
3.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2026-2031)
4 Therapeutic Proteins and Oral Vaccines Breakdown Data by Application
4.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Application (2020-2025)
4.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Therapeutic Proteins and Oral Vaccines Market Perspective (2020-2031)
5.2 Global Therapeutic Proteins and Oral Vaccines Growth Trends by Region
5.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Therapeutic Proteins and Oral Vaccines Historic Market Size by Region (2020-2025)
5.2.3 Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Region (2026-2031)
5.3 Therapeutic Proteins and Oral Vaccines Market Dynamics
5.3.1 Therapeutic Proteins and Oral Vaccines Industry Trends
5.3.2 Therapeutic Proteins and Oral Vaccines Market Drivers
5.3.3 Therapeutic Proteins and Oral Vaccines Market Challenges
5.3.4 Therapeutic Proteins and Oral Vaccines Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Therapeutic Proteins and Oral Vaccines Players by Revenue
6.1.1 Global Top Therapeutic Proteins and Oral Vaccines Players by Revenue (2020-2025)
6.1.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Players (2020-2025)
6.2 Global Therapeutic Proteins and Oral Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Therapeutic Proteins and Oral Vaccines Head Office and Area Served
6.4 Global Therapeutic Proteins and Oral Vaccines Players, Product Type & Application
6.5 Global Therapeutic Proteins and Oral Vaccines Manufacturers Established Date
6.6 Global Therapeutic Proteins and Oral Vaccines Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
7.2 North America Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
7.4 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
8.2 Europe Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
8.4 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
9.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
9.4 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
10.2 South America Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
10.4 South America Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size (2020-2031)
11.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025)
11.4 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Abbott
12.1.1 Abbott Company Information
12.1.2 Abbott Business Overview
12.1.3 Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.1.4 Abbott Therapeutic Proteins and Oral Vaccines Product Portfolio
12.1.5 Abbott Recent Developments
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Business Overview
12.2.3 Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.2.4 Sanofi Therapeutic Proteins and Oral Vaccines Product Portfolio
12.2.5 Sanofi Recent Developments
12.3 Merck
12.3.1 Merck Company Information
12.3.2 Merck Business Overview
12.3.3 Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.3.4 Merck Therapeutic Proteins and Oral Vaccines Product Portfolio
12.3.5 Merck Recent Developments
12.4 Roche
12.4.1 Roche Company Information
12.4.2 Roche Business Overview
12.4.3 Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.4.4 Roche Therapeutic Proteins and Oral Vaccines Product Portfolio
12.4.5 Roche Recent Developments
12.5 Pfizer
12.5.1 Pfizer Company Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.5.4 Pfizer Therapeutic Proteins and Oral Vaccines Product Portfolio
12.5.5 Pfizer Recent Developments
12.6 Amgen
12.6.1 Amgen Company Information
12.6.2 Amgen Business Overview
12.6.3 Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.6.4 Amgen Therapeutic Proteins and Oral Vaccines Product Portfolio
12.6.5 Amgen Recent Developments
12.7 TransAlgae
12.7.1 TransAlgae Company Information
12.7.2 TransAlgae Business Overview
12.7.3 TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.7.4 TransAlgae Therapeutic Proteins and Oral Vaccines Product Portfolio
12.7.5 TransAlgae Recent Developments
12.8 Serum Institute of India
12.8.1 Serum Institute of India Company Information
12.8.2 Serum Institute of India Business Overview
12.8.3 Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.8.4 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Portfolio
12.8.5 Serum Institute of India Recent Developments
12.9 Novo Nordisk
12.9.1 Novo Nordisk Company Information
12.9.2 Novo Nordisk Business Overview
12.9.3 Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.9.4 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Portfolio
12.9.5 Novo Nordisk Recent Developments
12.10 MigVax
12.10.1 MigVax Company Information
12.10.2 MigVax Business Overview
12.10.3 MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.10.4 MigVax Therapeutic Proteins and Oral Vaccines Product Portfolio
12.10.5 MigVax Recent Developments
12.11 Lumen Bioscience
12.11.1 Lumen Bioscience Company Information
12.11.2 Lumen Bioscience Business Overview
12.11.3 Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.11.4 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Portfolio
12.11.5 Lumen Bioscience Recent Developments
12.12 Johnson and Johnson
12.12.1 Johnson and Johnson Company Information
12.12.2 Johnson and Johnson Business Overview
12.12.3 Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.12.4 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Portfolio
12.12.5 Johnson and Johnson Recent Developments
12.13 Emergent Biosolutions
12.13.1 Emergent Biosolutions Company Information
12.13.2 Emergent Biosolutions Business Overview
12.13.3 Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.13.4 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Portfolio
12.13.5 Emergent Biosolutions Recent Developments
12.14 Eli Lilly and Company
12.14.1 Eli Lilly and Company Company Information
12.14.2 Eli Lilly and Company Business Overview
12.14.3 Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.14.4 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Portfolio
12.14.5 Eli Lilly and Company Recent Developments
12.15 Biogen
12.15.1 Biogen Company Information
12.15.2 Biogen Business Overview
12.15.3 Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2020-2025)
12.15.4 Biogen Therapeutic Proteins and Oral Vaccines Product Portfolio
12.15.5 Biogen Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.